证券代码：000615 证券简称：*ST美谷 公告编号：2023-102 奥园美谷科技股份有限公司 第十一届董事会第二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 奥园美谷科技股份有限公司（以下简称"公司"）第十一届董事会第二次会 议通知于 2023 年 8 月 4 日以电子邮件方式通知公司全体董事，会议于 2023 年 8 月 14 日下午以现场结合电子通讯的方式在公司会议室召开。本次会议由董事长 郭士国先生主持，会议应到董事 9 人，实到董事 9 人，公司部分监事、高级管理 人员列席了会议。会议的召集、召开程序符合《中华人民共和国公司法》和《公 司章程》的有关规定。经与会董事认真审议，通过了如下议案并形成决议，具体 情况如下： 一、审议通过了《2023 年半年度报告全文及摘要》 董事会认为：公司《2023 年半年度报告全文》及摘要的编制程序符合法律、 行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了公司的实际 情况，不存在虚假记载、误导性陈述或者重大遗漏。 具体内容详见同日刊登于《证券时报》《证券日报》和巨潮资讯网 （ www ...

关于使用闲置自有资金进行委托理财的公告 证券代码：000615 证券简称：*ST美谷 公告编号：2023-103 奥园美谷科技股份有限公司 公司下属控股子公司部分闲置自有资金。 3、委托理财种类 安全性高、流动性好具有合法经营资格的金融机构销售的理财类产品。 4、额度使用期限 自公司董事会审议通过之日起 12 个月内有效。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 奥园美谷科技股份有限公司（以下简称"公司"）于 2023 年 8 月 14 日召开 第十一届董事会第二次会议，审议通过了《关于使用闲置自有资金进行委托理财 的议案》，具体情况如下： 一、委托理财情况概述 1、委托理财金额 委托理财额度为期限内任一时点的委托理财交易金额不超过人民币 8,000 万元（含本数），在上述额度内，资金可以滚动使用。 2、资金来源 5、实施方式 董事会授权管理层在额度范围内行使相关决策权并签署合同文件，包括但不 限于：选择合格金融机构作为受托方、明确委托理财金额、期间、选择委托理财 产品品种、签署合同及协议等。由公司及子公司财务部负责具体操作事宜。 6、关联关系说明 公 ...

奥园美谷科技股份有限公司 独立董事工作制度 第一章 总则 第一条 为完善奥园美谷科技股份有限公司（以下简称"公司"）的公司 治理结构，充分发挥独立董事作用，促进公司独立董事尽责履职，保障全体股 东尤其是中小股东的合法权益不受损害，根据《中华人民共和国公司法》（以 下简称"《公司法》"）《上市公司治理准则》《上市公司独立董事管理办法》 《深圳证券交易所股票上市规则》（以下简称"《上市规则》"）《深圳证券交 易所上市公司自律监管指引第 1 号—主板上市公司规范运作》等法律法规 和《公司章程》的有关规定，并结合公司的实际情况，特制定本制度。 第二条 公司独立董事是指不在公司担任除董事外的其他职务，并与公司 及其主要股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响 其进行独立客观判断关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位 或者个人的影响。 独立董事工作制度 第三条 独立董事对公司及全体股东负有忠实与勤勉义务，应当按照法律、 行政法规、中国证券监督管理委员会（以下简称"中国证监会"）规定、证券 交易所业务规则和《公司章程》的规定，认真履行职责，在董事会中发挥参与 决策 ...

证券代码：000615 证券简称：*ST美谷 公告编号：2023-101 奥园美谷科技股份有限公司 关于股票交易异常波动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动情况 奥园美谷科技股份有限公司（以下简称"公司"）股票（证券简称：*ST 美 谷，证券代码：000615）连续三个交易日（2023 年 8 月 9 日、2023 年 8 月 10 日、2023 年 8 月 11 日）收盘价格涨幅偏离值累计超过 12%，根据《深圳证券交 易所交易规则》的有关规定，属于股票交易异常波动的情况。 二、公司关注、核实情况说明 针对公司股票异常波动，公司对有关事项进行了核查，现就有关情况说明 如下： 1、公司前期披露的信息不存在需要补充、更正之处。 2、公司未发现近期公共媒体报道了可能或已经对本公司股票交易价格产 生较大影响的未公开重大信息。 3、目前公司经营活动正常，内外部经营环境未发生或预计发生重大变化。 4、公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大 事项，或处于筹划阶段的重大事项。 5、经核查，公司控股股东、实际控制 ...

证券代码：000615 证券简称：*ST美谷 公告编号：2023-100 奥园美谷科技股份有限公司 关于收到中国证监会立案告知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 奥园美谷科技股份有限公司（以下简称"公司"）于 2023 年 8 月 8 日收到 中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》 （编号：证监立案字 0052023019），因公司涉嫌信息披露违法违规，根据《中 华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监 会决定对公司进行立案。 立案期间，公司将积极配合中国证监会的相关工作，并严格按照相关法律 法规及监管要求履行信息披露义务。 目前公司各项生产经营活动正常有序开展，本次立案不会对公司生产、经 营和管理造成重大影响。 公司指定的信息披露媒体为《证券时报》《证券日报》和巨潮资讯网 （www.cninfo.com.cn），有关公司信息均以前述指定媒体刊登的公告为准。敬 请广大投资者谨慎决策，注意投资风险。 特此公告。 奥园美谷科技股份有限公司 董事会 二〇二三年八月九日 1 ...

证券代码：000615 证券简称：*ST美谷 公告编号：2023-099 奥园美谷科技股份有限公司 关于公司控股股东质押情况的进展公告 种或多种方式对标的证券及其警息进行违约处置以及其他《信达证券有限公司股 票质拥式回购交易业务协议和风险揭示书》第七十条项下救济措施，具体处置数 量和金额以实际执行结果为准。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股东股份质押基本情况 截至本公告日，奥园美谷科技股份有限公司（以下简称"公司"）控股股东 深圳奥园科星投资有限公司（以下简称"奥园科星"）所持公司股份的质押情况： 1、奥园科星办理股票质押式回购交易时，所持公司股份 229,231,817 股， 质押股份数量占其所持股份比例为 75%，具体详见 2020 年 8 月 29 日刊登在巨潮 资讯网（www.cninfo.com.cn）的《关于控股股东进行股票质押式回购交易的公 告》。 2、中国东方资产管理股份有限公司重庆市分公司因公证债权文书未被履行 而向重庆市第五中级人民法院申请强制执行，被执行人为奥园科星、奥园集团有 限公司等，执行标的额合计 750,92 ...

Financial Position and Audit Concerns - The company received an audit report with a disclaimer of opinion for the 2022 financial statements, indicating significant uncertainties regarding its financial position [7]. - As of December 31, 2022, the company's net assets attributable to shareholders were negative, which will lead to a "delisting risk warning" on its stock trading [8]. - The management has expressed concerns about the company's ability to continue as a going concern due to the uncertainties highlighted in the audit reports [8]. - The company has been warned that its stock will face additional risk warnings due to negative net profit over the past three years [9]. - The company is facing a risk of delisting due to a negative net asset value at the end of 2022 and the disclaimer of opinion in the financial report, which will trigger a "delisting risk warning" on its stock trading [200]. - The board has been tasked with providing feasible plans for enhancing credit and introducing strategic investors to address significant debt risks [195]. - The independent directors have expressed understanding of the audit firm's disclaimer and have urged the management to take effective measures to minimize adverse impacts [197]. Revenue and Profitability - The company's operating revenue for 2022 was approximately ¥1.36 billion, a decrease of 14.66% compared to ¥1.54 billion in 2021 [25]. - The net loss attributable to shareholders was approximately ¥1.58 billion, representing a significant increase of 457.99% from a loss of ¥253 million in 2021 [25]. - Total revenue for the year 2022 was approximately ¥1.36 billion, a decrease of 14.66% compared to ¥1.59 billion in 2021 [57]. - Revenue from the medical beauty services segment increased by 41.59% to approximately ¥609.4 million, accounting for 44.94% of total revenue [57]. - Domestic revenue decreased by 21.23% to approximately ¥1.13 billion, while international revenue increased by 44.22% to approximately ¥229.8 million [59]. Legal and Regulatory Challenges - The company has faced legal challenges, including a lawsuit from China Cinda Asset Management Co., Ltd., which may impact its financial assessments [6]. - The company is currently involved in an arbitration case concerning a contractual dispute over 408 million RMB related to the sale of equity interests [186]. - The company has encountered significant litigation risks, including a major lawsuit from China Cinda Asset Management, which could impact its assets and operations [99]. Internal Controls and Governance - The internal control audit report revealed significant deficiencies in the company's internal controls [7]. - The internal control audit report issued a negative opinion, stating that the company failed to maintain effective internal controls over financial reporting as of December 31, 2022 [151]. - The internal control self-assessment report indicates that the total assets and operating income of the evaluated units account for 100% of the company's consolidated financial statements [149]. - The company has acknowledged issues with governance, including conflicts of interest involving independent directors and competition with controlling shareholders in similar business areas [153]. - The company has established a management system to prevent fund occupation by controlling shareholders and related parties, in compliance with regulatory requirements [191]. Strategic Focus and Market Position - The company is focused on the development of new products and technologies in the beauty and healthcare sectors [20]. - The company plans to expand its market presence and explore potential mergers and acquisitions to enhance growth [20]. - The company aims to become a leading brand in the beauty and health industry and an integrated player in the medical beauty ecosystem through acquisitions and partnerships [92]. - The company is exploring horizontal and vertical expansions in its product lines and may engage in mergers and acquisitions to adapt to market changes [98]. Environmental and Compliance Efforts - The company has established a comprehensive environmental management system, adhering to 60 relevant laws and regulations to ensure compliance and improve operational standards [157]. - The company has implemented ultra-low emission modifications on three boilers, achieving a reduction in total emissions: particulate matter decreased by 48.31%, nitrogen oxides by 63.57%, and sulfur dioxide by 72.87% compared to the previous year [161]. - The company has established a laboratory for manual monitoring of wastewater quality, conducting tests twice daily [167]. - The company is classified as a key regulatory unit for soil pollution in Xiangyang City, with monitoring results publicly disclosed [169]. Human Resources and Management - The company has a total of 2,615 employees, with 1,981 in production, 71 in sales, 344 in technology, 53 in finance, and 166 in administration [138]. - The company has implemented an employee stock ownership plan to incentivize staff [147]. - The company has a structured salary system based on job responsibilities, qualifications, and contributions, ensuring fair compensation for its management team [126]. - The company has established a performance evaluation system for senior management, ensuring compensation is based on job responsibilities and performance metrics [146]. Future Outlook and Growth Plans - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 20% to 1.8 billion yuan [178]. - New product development includes the launch of two innovative technologies aimed at enhancing user experience, expected to contribute an additional 200 million yuan in revenue [178]. - The company is planning market expansion into three new provinces, which is anticipated to increase market share by 10% [178]. - A strategic acquisition of a competitor is in progress, valued at approximately 500 million yuan, aimed at consolidating market position [178].

Goodwill Impairment - The company reported a goodwill impairment loss of approximately ¥38.50 million for Zhejiang Lantianmei Enterprise Management Co., Ltd. in the current year[12]. - The company has recognized a goodwill impairment loss of ¥7.29 million for Guangdong Aurora Health Management Consulting Co., Ltd.[12]. - The total carrying amount of goodwill for Zhejiang Lantianmei Enterprise Management Co., Ltd. was ¥650.97 million, with a corresponding impairment of ¥38.50 million[8]. - The total carrying amount of goodwill for the asset group of Guangdong Aurora Health Management Consulting Co., Ltd. was ¥7.29 million, with no impairment recognized[8]. - The goodwill value for Zhejiang Lantianmei is recorded at 650,966.79, with an impairment provision of 38,504,500[16]. - The company has recognized a goodwill impairment loss amounting to 38,504,500 for the current year[16]. Recoverable Amount and Future Cash Flows - The recoverable amount for Zhejiang Lantianmei Enterprise Management Co., Ltd. was estimated at ¥1.22 billion, while the carrying amount was ¥1.29 billion, indicating a potential impairment[12]. - The estimated future cash flows for the asset group of Zhejiang Lantianmei Enterprise Management Co., Ltd. were projected at ¥1.22 billion for the forecast period[11]. Revenue Growth Expectations - The company anticipates a revenue growth rate of 4.75% for the forecast period from 2023 to 2027 for Zhejiang Lantianmei Enterprise Management Co., Ltd.[11]. - The company expects a stable period revenue growth rate of 0% for the asset group of Zhejiang Lantianmei Enterprise Management Co., Ltd. beyond 2028[11]. Impairment Testing and Assumptions - The company has conducted a goodwill impairment test and found no impairment indicators for the asset group of United Navigation Asset Management Co., Ltd.[3]. - The company has made significant assumptions regarding the continuity of operations and market conditions in its impairment testing process[6]. Performance Decline - The annual performance of certain assets has declined by over 50%, highlighting potential financial distress[17]. - The company has not reversed the downward trend in performance for assets that experienced a decline of over 50%[18]. - There is a 55% equity stake in the related asset group, indicating a significant ownership interest[16].

Financial Performance - The company's revenue for Q1 2023 was ¥325,695,325.87, representing a 4.32% increase compared to ¥312,221,838.58 in the same period last year[7] - The net loss attributable to shareholders was ¥22,505,594.98, a 41.97% improvement from a loss of ¥38,781,641.68 in the previous year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥23,688,516.41, showing a 44.22% improvement from ¥42,469,118.77 in the previous year[7] - The total operating revenue for Q1 2023 was CNY 325,695,325.87, an increase of 4.73% compared to CNY 312,221,838.58 in Q1 2022[21] - The net loss for Q1 2023 was CNY 20,209,613.67, an improvement from a net loss of CNY 44,218,448.10 in Q1 2022[22] - The gross profit margin for Q1 2023 was approximately -4.06%, compared to -14.52% in Q1 2022[21][22] Cash Flow - The net cash flow from operating activities was ¥46,120,082.04, a significant increase of 171.12% compared to a negative cash flow of ¥64,848,599.50 in the same period last year[7] - In Q1 2023, the net cash flow from operating activities was ¥46,120,082.04, a significant improvement compared to a net outflow of ¥64,848,599.50 in Q1 2022[25] - The total cash inflow from investment activities was ¥56,880,826.92, while the cash outflow was ¥20,514,063.20, resulting in a net cash inflow of ¥36,366,763.72, compared to a net outflow of ¥21,397,022.81 in the same period last year[25] - The company reported a total cash inflow from operating activities of ¥327,074,365.47, compared to ¥924,368,669.27 in Q1 2022, indicating a decrease in operational cash generation[25] - The cash outflow for operating activities was ¥280,954,283.43, significantly lower than the ¥989,217,268.77 recorded in the previous year[25] - The cash flow from financing activities resulted in a net outflow of ¥18,177,291.48, compared to a net outflow of ¥129,150,457.14 in the same quarter last year[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,733,631,786.88, a decrease of 0.70% from ¥3,738,743,925.45 at the end of the previous year[7] - The total liabilities decreased slightly to CNY 3,522,392,175.46 from CNY 3,529,983,665.96 in the previous year[22] - The total equity attributable to shareholders of the parent company was CNY -182,448,874.74, worsening from CNY -161,383,279.76 in Q1 2022[22] - The equity attributable to shareholders decreased by 13.05% to -¥182,448,874.74 from -¥161,383,279.76 at the end of the previous year[7] Shareholder Information - Total number of common shareholders at the end of the reporting period is 92,506[14] - Shenzhen Aoyuan Kexing Investment Co., Ltd. holds 30.04% of shares, totaling 229,231,817 shares, with all shares frozen[14] - The company reported a total of 229,231,817 unrestricted shares held by major shareholders[15] Inventory and Investments - The company has a long-term equity investment of ¥13,885,543.53, up from ¥11,544,426.92, showing an increase of approximately 20.3%[18] - The company’s inventory decreased to ¥177,640,644.97 from ¥183,652,478.20, a reduction of about 3.7%[18] Government and Non-Recurring Items - The company recognized a government subsidy of ¥2,609,465.19 related to its normal operations[11] - The company reported a non-recurring gain of ¥248,268.33 from the disposal of non-current assets[10] - The company implemented a change in accounting policy that resulted in an increase in deferred tax assets and liabilities of ¥21,248,965.60 each[8] Research and Development - The company has ongoing research and development expenses amounting to CNY 6,237,512.80 for Q1 2023, slightly down from CNY 6,766,979.92 in Q1 2022[21] - The company has not disclosed any new product or technology developments in the current report[16] Future Outlook - The company aims to enhance its market position through strategic initiatives, although specific future outlooks were not detailed in the provided documents[22]

证券代码：000615 证券简称：奥园美谷 编号：2022-01 奥园美谷科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|-------------------------------|---------------------------------------------------------------------------------------------------| | | | | | | ☐ 特定对象调研 | ☐ 分析师会议 | | 投资者关系活动 | ☐ 媒体采访 | 业绩说明会 | | 类别 | ☐ 新闻发布会 | ☐ 路演活动 | | | ☐ 现场参观 | | | | ☐ | 其他（请文字说明其他活动内容） | | 形式 | ☐ 现场 网上 | ☐ 电话会议 | | 参与单位名称及人 | 线上参与公司 2021 | 年度网上业绩说明会的投资者 | | 员姓名 | | | | 时间 | 2022 年 05 月 18 日 | 15:00-17:00 | | 地点 | 网络互动平台：价值在线（ | www.i ...